Analysis of the state of implementation of digital technologies in pharmaceutical supply chain activities

Authors

  • A. G. Lisna National University of Pharmacy of the Ministry of Health of Ukraine, Kharkiv, Ukraine http://orcid.org/0000-0003-3863-8889
  • O. V. Posilkina National University of Pharmacy of the Ministry of Health of Ukraine, Kharkiv, Ukraine

DOI:

https://doi.org/10.24959/sphhcj.23.285

Keywords:

pharmaceutical industry; pharmaceutical supply chain; subjects of the pharmaceutical market; digitalization; digital technologies

Abstract

Aim. To study trends in the development of digital technologies in pharmacy, analyze the actual state of digitization of the domestic pharmaceutical industry and determine the impact of the implementation of digital technologies on the efficiency of the functioning of pharmaceutical supply chains and the ability of the latter to perform their socio-economic functions in new difficult economic conditions.

Materials and methods: To achieve the research goal, scientific sources on issues of digital logistics and transformational processes taking place in the pharmaceutical industry were analyzed. When conducting the research, the methods of information search, systematization, comparison and generalization were used, as well as the graphic method to increase the visibility of the presentation of the material.

Results. The relevance of digitalization of the pharmaceutical industry and the supply chain management in the conditions of the coronavirus pandemic and martial law to improve the reliability and safety of their functioning has been substantiated. A review of Ukraine’s positions in the global digital competitiveness rating for 2017-2021 has been conducted. The conditions that determine the digital transformation of pharmaceutical supply chains in various contexts have been identified. The current state of digitization of the domestic pharmaceutical industry has been analyzed. The classification of digital technologies has been systematized according to the degree of their impact on the development of pharmaceutical supply chains.

Conclusions. It has been proven that the domestic pharmaceutical production has already accumulated a certain potential and experience in using digital technologies, which opens up serious innovative prospects for improving logistics processes in pharmacy and increasing the reliability, safety and efficiency of pharmaceutical supply chains. The Covid epidemic and military operations have highlighted the weaknesses of domestic pharmaceutical logistics. And it is the active implementation of digital technologies in the activities of pharmaceutical market entities that will contribute to their successful solution.

References

Hromovyk, B. P., Unhurian, L. M. (2013). Farmatsevtychna lohistyka: fokus na dopomozi patsiientu. Lviv: Rastr-7, 212.

Unhurian, L. M., Hromovyk, B. P. (2016). Farmatsevtychna praktyka: lohistychni, informatsiini, neiroekonomichni ta sotsialni aspekty. Lviv: Prostir-M, 155.

Trokhymchuk, V. V., Shmatenko, O. P., Ubohov, S. H. (2007). Istoriia viiskovo-farmatsevtychnoi lohistyky. Kyiv: UVMA, 116.

Bilous, M. V., Shmatenko, O. P., Trokhymchuk, V. V. et al. (2019). Farmatsevtychnyi zhurnal, 3, 3-11.

Bilous, M. V. (2020). Proceeding from Sotsialna farmatsiia: stan, problemy ta perspektyvy : materialy VI Mizhnar. nauk.-prakt. internet-konf., 23-24 kvit. 2020 r. (pp. 344-346). Kharkiv : NFaU.

Bilous, M. V. (2014). Ekonomichnyi dyskurs, 3, 278-280.

Dondyk, N. Ya., Sincha, N. I., Lytvynenko, O. V. (2016). Suchasni IT u rozvytku farmatsevtychnoho biznesu v Ukraini. Available at: dspace.zsmu.edu.ua/bitstream/123456789/5790/1/%D0%90%D0%9F%D0%94%D0%9E%D0%A2_2016_90-92.pdf.

Pysarenko, T. V., Kuranda, T. K. et al. (2022). Naukova ta naukovo-tekhnichna diialnist v Ukraini u 2021 rotsi. Kyiv : UkrINTEI, 93.

IMD World Digital Competitiveness Ranking. (2021). Available at: tps://www.imd.org/news/updates/2021-world-competitiveness-ranking.

Lisna, A. H., Posylkina, O. V., Litvinova, O. V., Bratishko, Yu. S. (2022). Sotsialna farmatsiia v okhoroni zdorovia, 8 (1), 34-50. doi: https://doi.org/10.24959/sphhcj.22.244.

Povnistiu tsyfrove vyrobnytstvo – vyrobnytstvo z elektronnym dokumentoobihom. (2023). Available at: new.siemens.com/ua/uk/markets/farmatsevtychna-promyslovist/bezpaperov-tsyfrove-vyrobnytstvo.html.

Yevropeiske ahentstvo z likarskykh zasobiv. (2021). Available at: www.ema.europa.eu/en/news-events/whats-new.

Proektuvannia, budivnytstvo ta ekspluatatsiia farmatsevtychnykh i medyko-biolohichnykh pidpryiemstv. (2023). Available at: www.intergraph.soften.com.ua/haluzi/farmatsevtychna-haluz.html.

Suchasni biosensory i bioelektronni tekhnolohii. (2016). Available at: dspace.nbuv.gov.ua/bitstream/handle/123456789/104811/16-Terner.pdf?sequence=1.

Yak vidbuvaietsia tsyfrova transformatsiia biznesu v kompanii “Farmak” – lidera farmatsevtychnoho rynku Ukrainy. (2021). Available at: farmak.ua/publication/yak-vidbuvaetsya-czifrova-transformacziya-biznesu-v-kompaniyi-farmak-lidera-farmaczevtichnogo-rinku-ukrayini/.

Bridging digital divides in G20 countries. (2021). Available at: www.oecd.org/site/schoolingfortomorrowknowledgebase/themes/ict/bridgingthedigitaldivide.htm.

Derzhavna sluzhba statystyky Ukrainy. Vykorystannia informatsiino-komunikatsiinykh tekhnolohii na pidpryiemstvakh. Available at: ukrstat.gov.ua/operativ/operativ2018/zv/ikt/arh_ikt_u.html.

Downloads

Published

2023-09-06

Issue

Vol. 9 No. 2 (2023)

Section

Organizational and socio-economic bases of pharmaceutical activities

License

Copyright (c) 2023 National University of Pharmacy

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors who publish with this journal agree to the following terms:

  1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).